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Increased vascular superoxide anion (O 2
؊ ) formation is essentially involved in the pathophysiology of atherosclerosis. Chronic hyperglycemia induces endothelial dysfunction, probably due to increased formation of reactive oxygen intermediates. However, little is known about the localization, modulators, and molecular mechanisms of vascular O 2 ؊ formation during hyperglycemia. In porcine coronary segments, high glucose significantly increased O 2 ؊ formation (1,703.5 ؎ 394.9 vs. 834.1 ؎ 91.7 units/mg for control, n ‫؍‬ 64, P < 0.05; measured by lucigenin-enhanced chemiluminescence). This effect was completely blocked after removal of the endothelium. Coincubation with 10 mol/l atorvastatin, a lipophilic inhibitor of 3-hydroxy-3-methylglutarylcoenzyme A reductase, attenuated basal and glucoseinduced O 2 ؊ formation (328.1 ؎ 46.5 and 332.8 ؎ 50.3 units/mg, P < 0.05 vs. without atorvastatin). Incubation with mevalonic acid reversed this effect. High glucose increased mRNA expression of the oxidase subunit p22 phox , which was blocked by 10 mol/l atorvastatin, whereas expression of gp91 phox was unchanged. In conclusion, glucose-induced increase of vascular O 2 ؊ formation is endothelium dependent and is probably mediated by increased p22 phox subunit expression. Beneficial effects of statins in diabetic patients may be explained in part by attenuation of vascular O 2 ؊ formation independent of lipid lowering. Diabetes 51: 2648 -2652, 2002 R eactive oxygen intermediates contribute to the pathogenesis of atherosclerosis by lipid peroxidation and irreversibly modulate protein function by cross-linking and fragmentation of macromolecules (1, 2) . Furthermore, increased superoxide anion (O 2 Ϫ ) formation leads to cellular hypertrophy, to vascular dysfunction, probably as a result of increased formation of peroxynitrite, and to altered protein functions (3) (4) (5) . Free radicals in the vascular system have originally been thought to be generated by macrophages present in atherosclerotic plaques. However, nonphagocytic NAD(P)H-dependent oxidases have been identified in isolated vascular smooth muscle cells (VSMCs) (5), adventitia (6) , and endothelial cells (7) showing close molecular similarities to the phagocytic oxidase subunit p22 phox , a critical component of the vascular oxidase complex (4, 5) .
Hyperglycemia contributes to the pathogenesis of vascular complications in diabetes. Acute hyperglycemia induces reversible abnormalities in blood flow and vascular permeability by modulation of intracellular signaling pathways, followed by irreversible modifications of cellular proteins and vascular matrix during chronic hyperglycemia (1). Imbalances of endothelium-dependent nitric oxide generation and vascular O 2 Ϫ formation may explain endothelial dysfunction in diabetes (1) . Although increased O 2 Ϫ formation has been demonstrated (8), little is known about the molecular basis of elevated O 2 Ϫ formation during hyperglycemia.
Thus, the aim of the present study was to examine, in a tissue culture model of native coronary arteries, whether incubation with high glucose increases vascular O 2 Ϫ generation. We hypothesized that high glucose increases radical formation in endothelial cells via protein kinase C (PKC) activation, which leads to activation of NAD(H)-dependent oxidase at least partially due to increased expression of p22 phox expression. We further assumed that isoprenylation or some other action of hydroxymethylglutaryl (HMG)-CoA reductase is necessary to increase endothelial O 2 Ϫ production and p22 phox expression as determined after using the HMG-CoA reductase inhibitor atorvastatin.
RESEARCH DESIGN AND METHODS
Organ culture of porcine coronary arteries. Coronary arteries of porcine hearts (obtained from a local slaughterhouse) were cautiously dissected free of the adhering fat and connective tissue. Small segments (ϳ3-4 mm length) were cultured in Medium 199 (CC Pro, Neustadt, Germany) containing polymyxin B (5 g/ml). Rings were incubated with or without glucose (20 mmol/l) or sucrose (20 mmol/l) for up to 48 h (9). Endothelium was carefully removed 2 h before measurements in indicated experiments, and atorvastatin (1 or 10 mol/l) or vehicle was added. Cell viability (measured by MTT-based cytotoxicity assay) and proliferation (measured by BrdU-incorporation kit; Roche, Mannheim, Germany) of VSMCs (10, 11) and endothelial cells were not affected by up to 10 mol/l atorvastatin (not shown).
Measurement of vascular O 2
؊ formation. The formation of O 2 Ϫ in porcine coronary segments was measured in a HEPES-modified Krebs buffer (pH 7.40) and 250 or 4 mol/l lucigenin for 30-or 60-s intervals by a luminometer (Wallac, Freiburg, Germany). Averages of the plateau phase were used for further calculation (12) , and values were expressed as units per milligram dry weight (units/mg). Rings were incubated with inhibitors (diphenyleneiodonium, N G -nitro-L-arginine-methyl-ester, L-NAME, and oxypurinol) for 30 min before measurements as indicated. In some experiments, coronary rings were stimulated with NADH (100 mol/l) or NADPH (100 mol/l) and chemiluminescence was measured immediately. mRNA expression of NAD(P)H oxidase components in porcine coronary rings. The expression of p22 phox , gp91 phox , and glyceraldehyde-3-phosphate-dehydrogenase (G3PDH) mRNAs was evaluated in vascular rings incubated in medium for 48 h using competitive PCR after RT (Advantage RT-for-PCR Kit; Clontech, Palo Alto, CA) of 1 g RNA, which was isolated from three independent coronary rings (with or without endothelium) using TRIzol reagent (Life Technologies, Eggenstein, Germany). Nonhomologous internal standards with primer templates that are recognized by the genespecific primers were constructed (PCR MIMIC Construction Kit; Clontech), and cDNA from coronary rings was incubated with decreasing amounts of known standards and amplified with gene-specific primers: G3PDH: 5Ј-CCTCCACTACATGGTCTACATGTTCC-3Ј and 5Ј-CTCCACGATGCCGAAGTG GTCATGG-3Ј (24 cycles, annealing at 60°C, 402 bp; Genebank accession no. U48832); p22 phox : 5Ј-GTTGGTCTGCCTGCTGGAGT-3Ј and 5Ј-GTTGCTGGGC GGCTGCTTGAT-3Ј (29 cycles, annealing at 60°C, 324 bp; Genebank U02477); gp91 phox : 5Ј-GACTGTTCAAAGCCTGTGGC-3Ј, 5Ј-TCTCCTCATCATGGTGCA CG-3Ј (31 cycles, annealing at 60°C, 407 bp, Genebank U02476). Amplificated products were separated in 1.5% (wt/vol) agarose gels, and expression levels of ethidium-stained products of unknowns and standards were densitometrically determined ( 
RESULTS
Vascular O 2
؊ generation in coronary rings. Vascular O 2 Ϫ formation was 834.7 Ϯ 91.7 units/mg (n ϭ 64) after incubation of coronary rings for 48 h in medium 199 (using 250 mol/l lucigenin to measure chemoluminescence). Acute addition of NADH (100 mol/l) or NADPH (100 mol/l) at the end of this 48-h incubation period significantly increased O 2 Ϫ formation in the rings (NADH 4,502.4 Ϯ 412.1 units/mg and NADPH 2,261.0 Ϯ 304.1, n ϭ 17, P Ͻ 0.05 vs. baseline). O 2 Ϫ production was completely blocked to the background noise of the luminometer by adding the radical scavenger tiron (10 mmol/l; data not shown). Coincubation of rings with 20 mmol/l glucose for 48 h significantly increased vascular radical formation compared with control incubation with medium 199 ( At the end of the 48-h incubation period, O 2 Ϫ production of control and sucrose-treated rings was significantly reduced after removal of the endothelium (control 612.2 Ϯ 85.5 units/mg and sucrose 581.9 Ϯ 75.1, n ϭ 15, P ϭ 0.009 vs. with endothelium, using 250 mol/l lucigenin). Glucose-induced increases of O 2 Ϫ formation were completely blocked when the endothelium was removed (595.3 Ϯ 110.9 units/mg, NS versus respective controls). Coincubation of coronary rings with the HMG-CoA reductase inhibitor atorvastatin (10 mol/l) for 48 h reduced basal and NADH-stimulated O 2 Ϫ formation and blocked glucose-induced increases of vascular O 2 Ϫ generation ( Figs. 1 and 2) . Comparable results were obtained at a concentration of 4 mol/l lucigenin (coincubation with 10 mol/l atorvastatin 79.7 Ϯ 15.2 units/mg; high glucose with atorvastatin 72.1 Ϯ 14.3 units/mg, n ϭ 16, NS). Incubation with mevalonic acid (100 mol/l, using 250 mol/l lucigenin), which bypasses HMG-CoA-reductase inhibition, reversed atorvastatin-induced attenuation of basal and NADH-stimulated O 2 Ϫ production after control or high-glucose incubation of coronary rings (Fig. 2) . mRNA expression of G3PDH and NAD(P)H oxidase subunits. Expression of G3PDH and gp91 phox mRNA was not changed by incubation of coronary rings in high glucose or sucrose medium ( Table 1) . Expression of the p22 phox subunit was doubled after incubation in high glucose versus control or sucrose medium. Coincubation with atorvastatin (10 mol/l) reduced p22 phox expression and completely abolished the glucose-induced increase of p22 phox mRNA expression (Fig. 3) , whereas expression of gp91 phox and G3PDH-mRNA was not modulated. Removal of endothelium reduced expression of the p22 phox subunit (1.7 Ϯ 0.1 vs. 4.3 Ϯ 1.5 amol/g RNA with endothelium), whereas expression of gp91 phox was not changed (140.0 Ϯ 47.8 vs. 126.7 Ϯ 14.0 amol/g RNA with endothelium). In addition, removal of the endothelium completely blocked the increase of p22 phox subunit expression also in highglucose medium (1.7 Ϯ 0.4 amol/g RNA).
DISCUSSION
The present study demonstrates that, dependent on intact endothelium, high glucose elicits vascular O 2 Ϫ formation of native coronary arteries. In addition, high glucose upregulates the mRNA expression of the endothelial p22 phox subunit. Coincubation with atorvastatin, a HMGCoA reductase inhibitor, reduces coronary O 2 Ϫ generation and expression of p22 phox mRNA and completely blocks glucose-induced effects, presumably via a PKC-dependent pathway.
The glucose-induced increase of O 2 Ϫ formation in our organ culture model is obviously mediated by an increase of NAD(P)H-dependent oxidase activity. Involvement of eNOS or xanthine oxidase as a generator of vascular O 2 Ϫ formation was ruled out by preincubation of rings with L-NAME, a blocker of eNOS-mediated O 2 Ϫ generation (13), or with oxypurinol, an inhibitor of xanthine oxidase (14) . Upregulation of the p22 phox subunit mRNA suggests that p22 phox is the critical component of increased O 2 Ϫ generation in hyperglycemia, as previously reported for angiotensin II-dependent hypertension (4) . Removal of the endothelium reduces p22 phox mRNA expression, although gp91 phox mRNA expression was not changed. Although phox -mRNA is expressed ϳ30-fold higher than the p22 phox subunit, the relative expression level of p22 phox in the endothelium is probably higher than in the other cellular components of the coronary artery, whereas endothelial gp91 phox mRNA expression seems to be very low. The pathophysiological meaning of this uneven distribution of oxidase subunits is presently unclear. We hypothesize that the endothelium is a major source of vascular O 2 Ϫ and that the p22 phox subunit probably plays a dominant role in endothelium-dependent radical generation, at least in porcine coronary arteries.
Increase of p22 phox mRNA expression and coronary O 2 Ϫ formation is completely blocked after removal of the endothelium, providing convincing evidence that the endothelium is the critical mediator of increased O 2 Ϫ formation induced by high glucose concentrations. This contrasts with reports on angiotensin II-dependent hypertension (4) in which p22 phox expression was increased in VSMCs. Results of immunohistochemical examinations of human coronary arteries revealed that some endothelial cells and VSMCs aquire the ability to express p22 phox in atherosclerosis (15) . These findings propose that the cell types expressing p22 phox obviously depend on the triggering event and that the endothelium plays a prominent role in the pathogenesis of diabetic vascular complications. Because the PKC inhibitor staurosporine completely blocks glucose-dependent effects, we suggest that a PKCdependent pathway is essentially involved in the glucoseinduced increase of vascular O 2 Ϫ generation. The importance of PKC signaling is highlighted by recent reports that link activation of PKC with progression of diabetic vasculopathy (16) .
Respiratory burst in neutrophils is dependent on posttranslational isoprenylation of low molecular weight GTP binding proteins (LMWG) (17), such as rho or ras. Statins block isoprenylation by inhibition of HMG-CoA reductase, which synthesizes mevalonic acid, an immediate precursor of isoprenoids. Blockade of LMWG isoprenylation may reduce acitivity of NAD(P)H oxidase and expression of p22 phox , thus reducing basal and glucose-induced increases in O 2 Ϫ formation. Laufs and Liao (18, 19) demonstrated that inhibition of rho geranylgeranylation modulates expression of eNOs. In addition, Kim et al. (20) reported that the increased expression of fibronectin and transforming growth factor ␤1 by high glucose in mesangial cells is reduced by a lovastatin, presumably involving Rho family small GTP binding proteins. Thus, we speculate that atorvastatin reduces the active form of a LMWG, leading to a reduced transcription of p22 phox , whereas gp91 phox expression was not modulated. Involvement of protein isoprenylation in the effect of HMG-CoA reductase inhibition is further supported by reversibility of atorvastatin-induced effects by coincubation with mevalonic acid. The fold increase in O 2 Ϫ production by NADH, compared with basal, is greater after atorvastatin treatment, suggesting that the main effect of atorvastatin is on basal O 2 Ϫ generation. Effects of atorvastatin to reduce basal and glucose-induced increase in O 2 Ϫ formation appear at 1 mol/l and further increase at 10 mol/l. Maximum steadystate plasma concentrations of ϳ0.5 mol/l are seen in clinical studies. Thus, atorvastatin may be able to reduce O 2 Ϫ formation and p22 phox expression both in vitro and in vivo, contributing to the beneficial effects of HMG-CoA reductase inhibitors on atherosclerotic processes. This hypothesis is further supported by recent clinical studies suggesting beneficial anti-inflammatory effects of statins in addition to their lipid-lowering effects (21, 22) .
In conclusion, exposure to high glucose increases the expression of p22 phox , a critical component of nonphagocytic NAD(P)H-dependent oxidase, in native coronary 
